PRESS RELEASE published on 12/11/2023 at 15:20, 2 years 6 months ago Exploration Update of Vatu Aurum Gold Project, Fiji
PRESS RELEASE published on 09/27/2023 at 15:20, 2 years 9 months ago Kalo Discovers New Epithermal Gold and Copper Mineralization at Vatu Aurum Gold Project, Fiji
PRESS RELEASE published on 09/21/2023 at 13:00, 2 years 9 months ago Kalo Gold Identifies New Priority Epithermal Gold Targets With New Geological and Mineralization Model, Vatu Aurum Gold Project, Fiji
PRESS RELEASE published on 07/31/2023 at 15:20, 2 years 10 months ago Vatu Aurum Gold Project Cornerstone Permit Renewed
PRESS RELEASE published on 06/12/2023 at 15:20, 3 years ago Vatu Aurum Gold Project Exploration Update
PRESS RELEASE published on 01/11/2023 at 22:01, 3 years 5 months ago Kalo Gold Closes Non-Brokered Private Placement Offerings for Gross Proceeds of C$2,350,000, With Strategic Investments From Crescat Capital LLC and Associate Investors and a Foundation Owned and Controlled by Mr. Michael Gentile, CFA
Published on 06/30/2026 at 15:00, 1 hour 45 minutes ago Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Published on 06/30/2026 at 15:00, 1 hour 45 minutes ago BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Published on 06/30/2026 at 15:00, 1 hour 45 minutes ago Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Published on 06/30/2026 at 14:30, 2 hours 15 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 06/30/2026 at 14:00, 2 hours 45 minutes ago Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Published on 06/30/2026 at 16:34, 11 minutes ago hep global concludes fiscal year 2025 with a positive consolidated result
Published on 06/30/2026 at 16:05, 40 minutes ago Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
Published on 06/30/2026 at 15:06, 1 hour 39 minutes ago 260630 BENETEAU Transactions sur actions propres
Published on 06/30/2026 at 07:30, 9 hours 15 minutes ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:30, 9 hours 15 minutes ago Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
